Table 2 Continuous KELIM score is associated with platinum status.

From: STAR (stroma-tumor AI risk) assessment: association of AI-derived tumor-stroma proportion with patient survival provides added prognostic value beyond KELIM in epithelial ovarian cancer

Variable

Platinum sensitive (N = 67)

Platinum resistant (N = 22)

P valuea

KELIM score, median (range)

1.0 (0.3, 2.3)

0.7 (0.3, 2.0)

0.026

KELIM score, n (%)

  

0.066

 <1

37 (55.2%)

17 (77.3%)

 ≥1

30 (44.8%)

5 (22.7%)

TSPmanual, n (%)

  

0.293

 <50%

33 (49.3%)

8 (36.4%)

 ≥50%

34 (50.7%)

14 (63.6%)

TSPauto, n (%)

  

0.351

 <50%

32 (47.8%)

8 (36.4%)

 ≥50%

35 (52.2%)

14 (63.6%)

  1. Comparison of KELIM scores and TSP assessments by platinum status.
  2. aTo investigate the association between platinum status and continuous KELIM scores, Wilcoxon rank-sum was used. Chi-square tests were used for categorical KELIM scores and TSPauto/manual.
Back to article page